2016
DOI: 10.1007/s11655-015-2108-3
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic anti-tumor activity and mechanisms of total glycosides from Cimicifuga dahurica in combination with cisplatin

Abstract: TGCD enhanced the anticancer activity of CDDP in an additive-to-synergistic manner by activating multiple signaling pathways (including apoptosis). These fifi ndings suggest the potential benefifi t of combined treatment of the TGCD and CDDP against cancer of the colon and liver.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Limited information regarding the in vivo effects of actein on tumor growth, especially breast cancer, has ever been shown. Though the efficacies of extracts of other Cimicifuga species in tumor-bearing models were reported, the findings were controversy 20 21 22 23 24 . In the present study, the efficacies of actein on angiogenesis, breast tumor growth and metastasis in an immunocompetent mouse model were revealed for the first time.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Limited information regarding the in vivo effects of actein on tumor growth, especially breast cancer, has ever been shown. Though the efficacies of extracts of other Cimicifuga species in tumor-bearing models were reported, the findings were controversy 20 21 22 23 24 . In the present study, the efficacies of actein on angiogenesis, breast tumor growth and metastasis in an immunocompetent mouse model were revealed for the first time.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, the in vivo anti-tumor activities of extracts or active components from Cimicifuga species have been reported, such as extracts of C. racemosa in breast cancer rat model 20 , prostate cancer mouse model 21 and total glycosides from C. dahurica in hepatoma-bearing mice 22 23 . However, controversial findings were also observed in transgenic mice expressing c-erbB2, in which extract of C. racemosa increased metastatic mammary cancer 24 .…”
mentioning
confidence: 99%
“…In addition, total glycosides of C. dahurica against hepatoma through inducing cycle arrest and apoptosis in HepG2 cells and inhibiting the implanted mouse H22 tumor growth dose-dependently [ 74 ]. It elevated the anti-hepatoma activity and also had the ability to inhibit the growth of human colon cancer cells when combined with cisplatin [ 75 ]. Actein and 26-deoxyactein performed significant anti-tumor activity in 12 human cancer cell lines with the IC 50 range of 12.29 ~ 88.39 µg/mL in vitro .…”
Section: Pharmacological Activitiesmentioning
confidence: 99%